These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2718174)
41. Halogenated aryl hydrocarbon-induced suppression of the in vitro plaque-forming cell response to sheep red blood cells is not dependent on the Ah receptor. Davis D; Safe S Immunopharmacology; 1991; 21(3):183-90. PubMed ID: 1655676 [TBL] [Abstract][Full Text] [Related]
42. Mechanism of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonists: characterization of 6-[125I]methyl-8-iodo-1,3-dichlorodibenzofuran-Ah receptor complexes. Piskorska-Pliszczynska J; Astroff B; Zacharewski T; Harris M; Rosengren R; Morrison V; Safe L; Safe S Arch Biochem Biophys; 1991 Jan; 284(1):193-200. PubMed ID: 1846513 [TBL] [Abstract][Full Text] [Related]
43. AH receptor, ARNT, glucocorticoid receptor, EGF receptor, EGF, TGF alpha, TGF beta 1, TGF beta 2, and TGF beta 3 expression in human embryonic palate, and effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Abbott BD; Probst MR; Perdew GH; Buckalew AR Teratology; 1998 Aug; 58(2):30-43. PubMed ID: 9787404 [TBL] [Abstract][Full Text] [Related]
44. Retinoic acid and 2,3,7,8-tetrachlorodibenzo-p-dioxin selectively enhance teratogenesis in C57BL/6N mice. Birnbaum LS; Harris MW; Stocking LM; Clark AM; Morrissey RE Toxicol Appl Pharmacol; 1989 May; 98(3):487-500. PubMed ID: 2718176 [TBL] [Abstract][Full Text] [Related]
45. EGF and TGF-alpha expression influence the developmental toxicity of TCDD: dose response and AhR phenotype in EGF, TGF-alpha, and EGF + TGF-alpha knockout mice. Abbott BD; Buckalew AR; DeVito MJ; Ross D; Bryant PL; Schmid JE Toxicol Sci; 2003 Jan; 71(1):84-95. PubMed ID: 12520078 [TBL] [Abstract][Full Text] [Related]
46. Synergistic interaction of 2,3,7,8,-tetrachlorodibenzo-p-dioxin and hydrocortisone in the induction of cleft palate in mice. Birnbaum LS; Harris MW; Miller CP; Pratt RM; Lamb JC Teratology; 1986 Feb; 33(1):29-35. PubMed ID: 3738807 [TBL] [Abstract][Full Text] [Related]
47. Effects of TCDD on Ah receptor, ARNT, EGF, and TGF-alpha expression in embryonic mouse urinary tract. Bryant PL; Clark GC; Probst MR; Abbott BD Teratology; 1997 May; 55(5):326-37. PubMed ID: 9261927 [TBL] [Abstract][Full Text] [Related]
48. Relative potency values derived from hepatic vitamin A reduction in male and female Sprague-Dawley rats following subchronic dietary exposure to individual polychlorinated dibenzo-p-dioxin and dibenzofuran congeners and a mixture thereof. Fattore E; Trossvik C; HÃ¥kansson H Toxicol Appl Pharmacol; 2000 Jun; 165(3):184-94. PubMed ID: 10860868 [TBL] [Abstract][Full Text] [Related]
49. Structure-dependent induction of aryl hydrocarbon hydroxylase activity in C57BL/6 mice by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related congeners: mechanistic studies. Harris M; Zacharewski T; Piskorska-Pliszczynska J; Rosengren R; Safe S Toxicol Appl Pharmacol; 1990 Sep; 105(2):243-53. PubMed ID: 2219118 [TBL] [Abstract][Full Text] [Related]
50. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and 2,3,7,8-tetrachlorodibenzofuran (TCDF) in pregnant C57BL/6N mice: distribution to the embryo and excretion. Weber H; Birnbaum LS Arch Toxicol; 1985 Aug; 57(3):159-62. PubMed ID: 4062549 [TBL] [Abstract][Full Text] [Related]
51. Characterization of the Ah receptor mediating aryl hydrocarbon hydroxylase induction in the human liver cell line Hep G2. Roberts EA; Johnson KC; Harper PA; Okey AB Arch Biochem Biophys; 1990 Feb; 276(2):442-50. PubMed ID: 2154949 [TBL] [Abstract][Full Text] [Related]
52. 2,2',4,4',5,5'-hexachlorobiphenyl as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL/6J mice. Biegel L; Harris M; Davis D; Rosengren R; Safe L; Safe S Toxicol Appl Pharmacol; 1989 Mar; 97(3):561-71. PubMed ID: 2558429 [TBL] [Abstract][Full Text] [Related]
53. Incidence of jaw lesions and activity and gene expression of hepatic P4501A enzymes in mink (Mustela vison) exposed to dietary 2,3,7,8-tetrachlorodibenzo-p-dioxin, 2,3,7,8-tetrachlorodibenzofuran, and 2,3,4,7,8-pentachlorodibenzofuran. Bursian SJ; Moore J; Newsted JL; Link JE; Fitzgerald SD; Bello N; Bhat VS; Kay D; Zhang X; Wiseman S; Budinsky RA; Giesy JP; Zwiernik MJ Environ Toxicol Chem; 2012 Nov; 31(11):2545-56. PubMed ID: 22865772 [TBL] [Abstract][Full Text] [Related]
54. Effects of epidermal growth factor receptor deficiency and 2,3,7,8-tetrachlorodibenzo-p-dioxin on fetal development in mice. Miettinen HM; Huuskonen H; Partanen AM; Miettinen P; Tuomisto JT; Pohjanvirta R; Tuomisto J Toxicol Lett; 2004 May; 150(3):285-91. PubMed ID: 15110080 [TBL] [Abstract][Full Text] [Related]
55. Differential relative effect potencies of some dioxin-like compounds in human peripheral blood lymphocytes and murine splenic cells. van Ede KI; Gaisch KP; van den Berg M; van Duursen MB Toxicol Lett; 2014 Apr; 226(1):43-52. PubMed ID: 24472611 [TBL] [Abstract][Full Text] [Related]
56. Kinetics of the association of several tritiated polychlorinated dibenzo-p-dioxin and dibenzofuran congeners with hepatic cytosolic Ah receptor from the Wistar rat. Rosengren R; Safe S; Bunce NJ Chem Res Toxicol; 1992; 5(3):376-82. PubMed ID: 1324021 [TBL] [Abstract][Full Text] [Related]
57. 2,3,7,8-Tetrachlorodibenzo-p-dioxin as growth modulator in mouse hepatocytes with high and low affinity Ah receptor. Schrenk D; Schäfer S; Bock KW Carcinogenesis; 1994 Jan; 15(1):27-31. PubMed ID: 8293544 [TBL] [Abstract][Full Text] [Related]
58. Toxic interaction of specific polychlorinated biphenyls and 2,3,7,8-tetrachlorodibenzo-p-dioxin: increased incidence of cleft palate in mice. Birnbaum LS; Weber H; Harris MW; Lamb JC; McKinney JD Toxicol Appl Pharmacol; 1985 Feb; 77(2):292-302. PubMed ID: 3919463 [TBL] [Abstract][Full Text] [Related]
59. Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-lodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonist for the Ah receptor. Poland A; Teitelbaum P; Glover E; Kende A Mol Pharmacol; 1989 Jul; 36(1):121-7. PubMed ID: 2546046 [TBL] [Abstract][Full Text] [Related]
60. TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministration of retinoic acid and TCDD. Abbott BD; Birnbaum LS Toxicol Appl Pharmacol; 1990 Dec; 106(3):418-32. PubMed ID: 2260090 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]